UPDATE ON DIABETES AND CVD: 3ND EDITION MEETING IN COOPERATIONBETWEEN: D&CVD STUDY GROUP (REFERENCE STUDY GROUP OF EASD)

The presence of hyperglycemia associated with the well-known risk factors of metabolic syndrome and diabetes itself predispose to important cardiovascular complications which have a strong impact on the quality of life of the individual and on the community in general, also from an economic point of view. The cardio-vascular-renal complications of diabetes still represent the major cause of mortality and disability of people affected by it, resulting in hospital admission in over 75% of cases.
In recent years, we have available different categories of drugs with proven effects of positive action on the significant reduction of cardiovascular and renal events; recommended consequently in national and international guidelines, as early use for the treatment of diabetes.
It is of the utmost importance to assess cardiovascular risk in individuals with diabetes who do not yet have clinical evidence of cardiovascular disease, in order to identify those at the highest risk, in which maximum prevention must be immediately activated, correcting lifestyles and implementing the most appropriate therapy. From stratification of cardiovascular risk to screening, diagnosis and treatment. The new Guidelines for cardiovascular diseases, in people with diabetes, of the European Society of Cardiology (ESC), evaluate and summarize the available scientific evidence, with the aim of supporting health professionals in proposing the best diagnostic and therapeutic approach.
The purpose, therefore, of this course is to deepen and update the current knowledge of prevention of diabetes complications, with maximum interactivity between cardiologists and diabetologists; deepening the epidemiology and pathogenesis of renal and cardiovascular diseases, the possible mechanisms of action in the demonstrated prevention, the comparison of the different therapeutic approaches and the possible advantages of an early and more generalized use.

16 e 17 gennaio 2026
Evento residenziale presso:
Collegio Ghisleri piazza Ghisleri n.5 - Pavia

Al termine ogni partecipante dovrà sostenere un test di valutazione e compilare il modulo di qualità percepita attraverso la piattaforma
PASSAGGIO OBBLIGATORIO PER CONSEGUIRE I CREDITI ECM PREVISTI
Test e modulo si dovranno compilare entro il 20/01/2026

Attenzione: 

• numero massimo di tentativi a diposizione: 1
• soglia di superamento: 75% delle risposte corrette

IL PROGRAMMA È DISPONIBILE CLICCANDO "Locandina" IN ALTO PAGINA o "Allegati" A FONDO PAGINA

Questionario a risposta multipla e doppia randomizzazione da compilare tramite la piattaforma entro il 20/01/2026

Attenzione: 

• numero massimo di tentativi a diposizione: 1
• soglia di superamento: 75% delle risposte corrette

. SERIE DI RELAZIONI SU TEMA PREORDINATO
. CONFRONTO/DIBATTITO TRA PUBBLICO ED ESPERTO/I GUIDATO DA UN CONDUTTORE ("L'ESPERTO RISPONDE")